Daiichi Sankyo · flagship
Daiichi Sankyo pairs LINK AI drafting with TrialAssure’s medical writers
- Up to 80%
- faster delivery
- ~50%
- lower cost/document
Named customers. Real numbers. No composites.
TrialAssure® technology is used across pharmaceutical, biotech, research, and service-provider organizations. The TrialAssure case studies below share the results we are permitted to publish, with customers anonymized and hedges preserved because that’s what real numbers look like.
The shared model
Sponsors and providers on one record.
Most engagements here involve a sponsor and a service provider working the same study. TrialAssure gives both sides technology built around the same transparency work, reducing unnecessary handoffs and duplicate effort.
More customer stories
Cancer Research UK CDD
TrialAssure LINK® AI for regulatory and clinical documents — their writers central to every review.
See LINK AI →Certara
TrialAssure ANONYMIZE® licensed since 2021 — 850,000+ pages, 250+ projects.
See ANONYMIZE →Top-10 pharma (anonymous)
CSR hours cut ~90% with LINK AI.
See LINK AI →Sponsor (anonymous)
Anonymization processing time down up to 80%.
See ANONYMIZE →Cancer Research UK’s Centre for Drug Development uses LINK AI to draft regulatory and clinical trial documents — with its own medical writers central to every review.
The flexibility in workflow makes it a tool easily implemented in just about any organization.
TrialAssure is the perfect partner in this space. Their AI knowledge and their AI-enabled software will allow us to co-create a solution that doesn’t exist in the market today.
TrialAssure’s expertise and technology make navigating complex regulatory frameworks seamless.
What counts as proof on this page
Results from real engagements, including figures customers have approved for publication. There are no composites and no invented averages here: every number below came out of a real engagement, and where a figure is hedged — “up to”, “around” — the hedge is in the original rather than added for comfort.
Why some customers are anonymous
Many sponsors and service providers prefer not to be named in vendor marketing. Rather than leave those engagements out or turn them into composites, we publish the results we are permitted to share and describe each organization only as far as we are permitted.
What the numbers are measured against
Each figure compares a specific engagement to how that same team worked before, which is why the ranges are wide and the hedges stay in. Document mix, review policy and starting maturity all move the result. Anyone quoting a single precise percentage for this category of work is describing one project and calling it a benchmark.
The engagement that runs in public
The clearest evidence is not a testimonial but a service provider betting its own delivery on the platform. Certara has licensed ANONYMIZE since 2021 and runs it inside its own regulatory-science work — 850,000+ pages anonymized across 250+ projects. That is the model operating at scale, under someone else’s brand, in the open.
TrialAssure case studies
Accelerating AI-Augmented CSR Development for a Top Global Biopharma Sponsor
How Daiichi Sankyo Accelerated Plain Language Summary Development with TrialAssure LINK AI
How Certara and TrialAssure Partner to Deliver Faster, Compliant Anonymization for Global Sponsors
How MMS and TrialAssure Engaged AI to Improve the Quality and Delivery in Producing Informed Consent Forms (ICFs) and other Regulatory Documents
How a Clinical-Stage Biotech Accelerated Secure Clinical Trial Data Sharing 80% Faster with TrialAssure
See it on your own studies
Get a demo
Trusted by 8 of the top 10 clinical development companies